Monoclonal antibodies to Ebola glycoprotein
US6630144B1 · kind B1 · utility
28Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2000 |
| Grant date | Oct 7, 2003 |
| Priority date | — |
| Expiry date | Aug 29, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/14134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In this application are described Ebola GP monoclonal antibodies and epitopes recognized by these monoclonal antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of Ebola virus infections in vitro and in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.